Delivery Order SPE2DR25D1100-SPE2DR26FCR6B
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,282.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) valued at $11,211.06. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among all eligible vendors....
- The Defense Logistics Agency awarded a delivery order valued at $1,892.42 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 80-12.5 mg tablets in quantities of 90, with delivery to conclude by December 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,397.13 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-12.5 mg tablets (90-count supply) on September 24, 2025, with completion scheduled for September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $29,710.91 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a quantity of 90 units. The contract was competitively awarded without set-aside designation under a firm fixed price arrangement, with an ultimate completion date of November 4, 2025. The award was issued on November 3, 2025, and the pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $13,169.83 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a delivery order valued at $1,812.04 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a 90-count quantity. The contract, which became effective on October 27, 2025, with an ultimate completion date of October 28, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,505.49 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion and extending through December 2026. The...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCR6BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-25 mg tablets (90-count supply) on November 26, 2025, with completion scheduled for November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under a competitive contracting mechanism, consistent with DLA's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor vehicle valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical procurement vendor is reflected in its portfolio of competitively awarded contracts covering a broad spectrum of therapeutic domains, from specialty medications to generic drugs and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/25/25 |